Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Glutamate hypothesis of depression and its consequences for antidepressant treatments.

Musazzi L, Treccani G, Popoli M.

Expert Rev Neurother. 2012 Oct;12(10):1169-72. doi: 10.1586/ern.12.96. No abstract available.

PMID:
23082730
[PubMed - indexed for MEDLINE]
2.

Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target.

Goeldner C, Ballard TM, Knoflach F, Wichmann J, Gatti S, Umbricht D.

Neuropharmacology. 2013 Jan;64:337-46. doi: 10.1016/j.neuropharm.2012.08.001. Epub 2012 Aug 23. Review.

PMID:
22992331
[PubMed - indexed for MEDLINE]
3.

An update on the role of glutamate in the pathophysiology of depression.

Mitchell ND, Baker GB.

Acta Psychiatr Scand. 2010 Sep;122(3):192-210. doi: 10.1111/j.1600-0447.2009.01529.x. Epub 2010 Jan 25. Review.

PMID:
20105149
[PubMed - indexed for MEDLINE]
4.

Psychiatric drugs. Excited by glutamate.

Holden C.

Science. 2003 Jun 20;300(5627):1866-8. No abstract available.

PMID:
12817119
[PubMed - indexed for MEDLINE]
5.

Modulation of glutamate receptors: strategies for the development of novel antidepressants.

Skolnick P.

Amino Acids. 2002;23(1-3):153-9. Review.

PMID:
12373530
[PubMed - indexed for MEDLINE]
6.

New perspectives on glutamate receptor antagonists as antidepressants.

Chung C.

Arch Pharm Res. 2012 Mar;35(4):573-7. doi: 10.1007/s12272-012-0400-8. Review.

PMID:
22553049
[PubMed - indexed for MEDLINE]
7.

Ketamine as an alternative treatment for treatment-resistant depression.

Dowben JS, Grant JS, Keltner NL.

Perspect Psychiatr Care. 2013 Jan;49(1):2-4. doi: 10.1111/ppc.12006. Epub 2012 Dec 30. Review. No abstract available.

PMID:
23293991
[PubMed - indexed for MEDLINE]
8.

[Glutamatergic neurotransmission, depression and antidepressants].

Ferrero A, Cereseto M.

Vertex. 2004 Jun-Aug;15(56):91-8. Review. Spanish.

PMID:
15243652
[PubMed - indexed for MEDLINE]
9.

mGlu2/3 and mGlu5 receptors: potential targets for novel antidepressants.

Chaki S, Ago Y, Palucha-Paniewiera A, Matrisciano F, Pilc A.

Neuropharmacology. 2013 Mar;66:40-52. doi: 10.1016/j.neuropharm.2012.05.022. Epub 2012 May 26. Review.

PMID:
22640631
[PubMed - indexed for MEDLINE]
10.

The role of glutamate on the action of antidepressants.

Hashimoto K.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1558-68. doi: 10.1016/j.pnpbp.2010.06.013. Epub 2010 Jun 20. Review.

PMID:
20600468
[PubMed - indexed for MEDLINE]
11.

Glutamate uptake.

Danbolt NC.

Prog Neurobiol. 2001 Sep;65(1):1-105. Review.

PMID:
11369436
[PubMed - indexed for MEDLINE]
12.

Two case studies of patients with major depressive disorder given low-dose (subanesthetic) ketamine infusions.

Correll GE, Futter GE.

Pain Med. 2006 Jan-Feb;7(1):92-5. No abstract available.

PMID:
16533209
[PubMed - indexed for MEDLINE]
13.

The NMDA receptor as a therapeutic target in major depressive disorder.

Pittenger C, Sanacora G, Krystal JH.

CNS Neurol Disord Drug Targets. 2007 Apr;6(2):101-15. Review.

PMID:
17430148
[PubMed - indexed for MEDLINE]
14.

Are compounds acting at metabotropic glutamate receptors the answer to treating depression?

Palucha A.

Expert Opin Investig Drugs. 2006 Dec;15(12):1545-53. Review.

PMID:
17107280
[PubMed - indexed for MEDLINE]
15.

Metabotropic glutamate receptors in the control of mood disorders.

Witkin JM, Marek GJ, Johnson BG, Schoepp DD.

CNS Neurol Disord Drug Targets. 2007 Apr;6(2):87-100. Review.

PMID:
17430147
[PubMed - indexed for MEDLINE]
16.

Open questions in current models of antidepressant action.

Tanti A, Belzung C.

Br J Pharmacol. 2010 Mar;159(6):1187-200. doi: 10.1111/j.1476-5381.2009.00585.x. Epub 2010 Feb 2. Review.

PMID:
20132212
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

[The role of the glutamatergic system in pathophysiology and pharmacotherapy for depression: preclinical and clinical data].

Paslakis G, Gass P, Deuschle M.

Fortschr Neurol Psychiatr. 2011 Apr;79(4):204-12. doi: 10.1055/s-0029-1245770. Epub 2010 Nov 29. Review. German.

PMID:
21117011
[PubMed - indexed for MEDLINE]
18.

Glutamatergic approaches in major depressive disorder: focus on ketamine, memantine and riluzole.

Owen RT.

Drugs Today (Barc). 2012 Jul;48(7):469-78. doi: 10.1358/dot.2012.48.7.1832873. Review.

PMID:
22844658
[PubMed - indexed for MEDLINE]
19.

Formation of perineuronal nets in organotypic mouse brain slice cultures is independent of neuronal glutamatergic activity.

Reimers S, Hartlage-Rübsamen M, Brückner G, Rossner S.

Eur J Neurosci. 2007 May;25(9):2640-8.

PMID:
17561838
[PubMed - indexed for MEDLINE]
20.

Dopamine enhancement and depression of glutamate-regulated calcium and electrical activity in hypothalamic neurons.

van den Pol AN, Cao V, Belousov AB.

J Neurophysiol. 1996 Dec;76(6):3934-48.

PMID:
8985891
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk